The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Dynamic analysis of CA-125 decline during neoadjuvant chemotherapy in patients with epithelial ovarian cancer as a predictor for sensitivity to platinum.
Roman Rouzier
No relevant relationships to disclose
Aurelie Pelissier
No relevant relationships to disclose
Claire Bonneau
No relevant relationships to disclose
Elisabeth Chereau
No relevant relationships to disclose
Virginie Fourchotte
No relevant relationships to disclose
Emile Darai
No relevant relationships to disclose
Thibault De La Motte Rouge
No relevant relationships to disclose